Betty D. Larson - 30 Apr 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP, Chief HR Officer
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Betty Larson
Issuer symbol
MRK
Transactions as of
30 Apr 2024
Net transactions value
$0
Form type
4
Filing time
02 May 2024, 16:25:48 UTC
Previous filing
08 Apr 2024
Next filing
02 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +34,050 $0.000000 34,050 30 Apr 2024 Common Stock 34,050 Direct F1, F2
transaction MRK Stock Option (Right to Buy) Award $0 +58,594 $0.000000 58,594 30 Apr 2024 Common Stock 58,594 $129.22 Direct F3
transaction MRK Stock Option (Right to Buy) Award $0 +31,055 $0.000000 31,055 30 Apr 2024 Common Stock 31,055 $129.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
F3 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

Remarks:

See Exhibit 24 - Power of Attorney.